Navigation Links
New Information on the Potential of Plasmin Shared at ISTH Congress

e improved patient outcomes, and these are currently being evaluated in the clinic."

About Plasmin (Human), TAL-05-00018

Plasmin (Human), TAL-05-00018, is a plasma-derived thrombolytic protein currently under development by Talecris Biotherapeutics for treating acute peripheral arterial occlusion. Plasmin is a catheter-delivered, direct and locally acting, fibrin-specific thrombolytic with additional potential applications in other acute bleeding disorders including deep vein thrombosis and ischemic stroke. The plasmin molecule contains fibrin-binding domains not present in other direct thrombolytics. Plasmin is rapidly inactivated by alpha-2 antiplasmin when not bound to fibrin therefore minimizing risk of systemic bleeding.

(delta) plasmin, TAL-6003

Talecris scientists are utilizing biotechnology applications to produce modified Plasmin molecules that may exhibit improved fibrinolytic properties. (delta) plasmin ((delta)Pm), TAL-6003, is a simplified form of human plasmin where Kringle 1, which carries the fibrin and alpha-2 antiplasmin-binding site, is directly attached to the serine protease domain. Early research on this modified form of the plasmin molecule reinforces the importance of fibrin binding for its fibrinolytic potency. This attribute is critical for direct thrombolytics to maintain efficacy under dynamic flow conditions, i.e., not get washed away from the clot as blood flow begins to be restored.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, and hemostasis. Talecris is proudly building upon a 60-year legacy of innovation and a commitment to improving the lives of people who rely on its therapeutic products. With an emphasis on scientific
'"/>




Page: 1 2 3 4

Related medicine technology :

1. International Movement Disorder Specialists Receive New Information About the Use of Once-Daily Azilect in the Treatment of Parkinsons Disease
2. FDA Announces Audio Broadcasts on Emerging Drug Safety Information
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
5. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
6. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
7. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
8. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
9. Expert Opinion Highlights Avigens AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal
10. New Study Shows That telmisartan has Greater Renoprotective Potential Thanlosartan in Hypertensive Patients With Type 2 Diabetes
11. Pluristems PLX Cells Demonstrate Potential to Treat Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Information the Potential Plasmin Shared ISTH Congress
(Date:9/2/2014)... , Sept. 2, 2014  Hologic, Inc. (NASDAQ: ... and Chief Executive Officer, will present at the Morgan Stanley ... , New York on Tuesday, September ... parties are invited to listen to the live audio webcast ... at www.hologic.com/investors-overview . An archive of the presentation will ...
(Date:9/2/2014)... SEATTLE , Sept. 2, 2014 /PRNewswire/ ... company committed to the development and commercialization ... today announced an update on corporate and ... structure, commitment for future funding, ongoing clinical ... In corporate news, Chief Executive Officer ...
(Date:9/2/2014)...  BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a ... XIAFLEX ® in the U.S. and XIAPEX ® ... Wegman , will present at the following upcoming investor conferences. ... & Renshaw 16 th Annual Global Investment Conference ... 9, 2014 at 9:10 a.m. EDT , Aegis ...
Breaking Medicine Technology:VentiRx Pharmaceuticals Provides Corporate and Clinical Update 2VentiRx Pharmaceuticals Provides Corporate and Clinical Update 3BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2
... (NASDAQ: AMRI ), a global contract services organization ... as part of its ongoing global operations review to improve ... its European operations focused on a reduction of the workforce ... at its Budapest, Hungary operation. As a ...
... Jan. 9, 2012  Xenon today announced a strategic alliance ... RO, ROG; OTCQX: RHHBY), to discover and develop compounds ... "We are delighted to be collaborating with ... "Genentech is among the world,s leading biotech companies and ...
Cached Medicine Technology:AMRI Announces Review of Its Hungary Operation 2AMRI Announces Review of Its Hungary Operation 3Xenon to Collaborate with Genentech on Discovery of Novel Targeted Pain Therapeutics 2
(Date:9/2/2014)... September 02, 2014 The new ... to reduce discomfort and fatigue by absorbing stress and ... eco-friendly, renewable bio-foam core, these anti-fatigue mats are intended ... According to a study by the Texas A&M University, ... difference in reducing spinal compression and increase in sit-reach ...
(Date:9/2/2014)... A little white pill may help scientists learn why ... their peers, even if their lungs are relatively healthy. ... marketed as Revatio to treat pulmonary hypertension and Viagra ... of over-the-counter antioxidants will help them identify the root ... for these patients. , "We want to understand ...
(Date:9/2/2014)... increasing concern to health officials both in NYC and ... Health and Mental Hygiene, the number of unintentional opioid-involved ... of such deaths in 2000. Much of the increase ... prescription opioid (PO) use among teens and young adults, ... transitioned from POs to heroin. , Now researchers ...
(Date:9/2/2014)... new guideline, the Society for Maternal-Fetal Medicine has recommended ... , "There is no evidence that bed rest ... Center for Maternal and Fetal Medicine and one of ... that bed rest can be harmful for moms, babies, ... are placed on bed rest during their pregnancy. Surveys ...
(Date:9/2/2014)... -- Many people believe that marijuana is not addictive, ... more people are able to obtain and consume cannabis ... people are less likely to perceive it as addictive ... Massachusetts General Hospital,s Center for Addiction Medicine, said in ... cannabis use can have significant consequences, and we know ...
Breaking Medicine News(10 mins):Health News:New Eco-Pro Premium Anti-fatigue Mats from Martinson-Nicholls Prevent Fatigue and Discomfort for Standing Workers 2Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 2Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 3Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 4Health News:NYC teens and young adults who abuse prescription at high risk for overdose 2Health News:NYC teens and young adults who abuse prescription at high risk for overdose 3Health News:SMFM releases paper on activity restriction in pregnancy 2Health News:'Pot Addiction' May Be Real, Study Suggests 2
... Intimidation often takes place during the school day, survey ... is often assumed that the schoolyard is where bullies ... study suggests that classrooms are another popular site. ... Health Association,s annual meeting in Philadelphia, is based on ...
... deductibles and offering little gap coverage , FRIDAY, ... standalone Medicare prescription drugs plans (PDP) could encounter significant ... Monthly premiums will rise 11 percent to $38.94, on ... J. Kaiser Family Foundation. That,s up 50 percent from ...
... citizens managing diabetes and vision loss have ... to help them learn how to stay active, eat sensibly and ... expanded AFB Senior Site ( www.afb.org/seniorsite/diabetes ... at Ruth Eckerd Hall in recognition of American Diabetes ...
... that they are similar in many respects to the body,s ... Institutet have found a new way of tackling colon cancer. ... . Molecular signal pathways that stimulate the division of ... tumour growth. This limits the possibility of treating cancer as ...
... - Researchers from Boston University School of Medicine (BUSM) have ... around the heart and the aorta and within the liver, ... appears on-line in Obesity , also found that measuring ... the amount of undesired fat in and around these vital ...
... ... first aid products designed for active lifestyles, today announced its participation at the Silicon ... , ... (PRWEB) November 13, 2009 -- Tender Corp ., a leading manufacturer of over-the-counter ...
Cached Medicine News:Health News:Many Kids Feel Threatened in the Classroom 2Health News:Medicare Part D: What to Expect This Open Enrollment Period 2Health News:Medicare Part D: What to Expect This Open Enrollment Period 3Health News:AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 2Health News:AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 3Health News:AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 4Health News:Paradoxical protein might prevent cancer 2Health News:Fat collections linked to decreased heart function 2Health News:Tender Corp. Announces Participation at Silicon Valley Moms Group's Holiday Coupon Guide & Party 2Health News:Tender Corp. Announces Participation at Silicon Valley Moms Group's Holiday Coupon Guide & Party 3Health News:Tender Corp. Announces Participation at Silicon Valley Moms Group's Holiday Coupon Guide & Party 4Health News:Tender Corp. Announces Participation at Silicon Valley Moms Group's Holiday Coupon Guide & Party 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: